HALLIBURTON CO

HAL

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 65,344Value: $1.9M

**Signal Note:** Eventide's initiation of a $1.9M HAL position is notable given the firm's strict values-based screening—this suggests Halliburton's energy services business (oil/gas infrastructure) now meets ESG thresholds, likely reflecting portfolio rebalancing rather than biotech-specific catalyst. This position sits outside Eventide's core biotech competency and appears opportunistic rather than conviction-driven, warranting monitoring for whether additional biotech-focused trades follow.

More HAL Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: